Leaky vessels and poor drainage from tumours were predicted to be positive features helping to promote deposition and accumulation of anti-cancer drugs delivered via nanoparticles. But so far outcomes have been disappointing. Now, by activating a protein called STING to enhance vessel leakiness combined with a bifunctional nanoscale polymer, anti-tumour immunotherapy can be efficiently induced
Read the published research article here
Written by
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.